» Articles » PMID: 18362211

Abnormal Muscle Spindle Innervation and Large-fiber Neuropathy in Diabetic Mice

Overview
Journal Diabetes
Specialty Endocrinology
Date 2008 Mar 26
PMID 18362211
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Large-fiber diabetic polyneuropathy (DPN) leads to balance and gait abnormalities, placing patients at risk for falls. Large sensory axons innervating muscle spindles provide feedback for balance and gait and, when damaged, can cause altered sensorimotor function. This study aimed to determine whether symptoms of large-fiber DPN in type 1 and type 2 diabetic mouse models are related to alterations in muscle spindle innervation. In addition, diabetic mice were treated with insulin to assess whether sensorimotor and spindle deficits were reversible.

Research Design And Methods: Behavioral assessments were performed in untreated and treated streptozotocin (STZ)-injected C57BL/6 mice to quantitate diabetes-induced deficits in balance and gait. Quantification of Ia axon innervation of spindles was carried out using immunohistochemistry and confocal microscopy on STZ-injected C57BL/6 and db/db mice.

Results: STZ-injected C57BL/6 mice displayed significant and progressive sensorimotor dysfunction. Analysis of Ia innervation patterns of diabetic C57BL/6 spindles revealed a range of abnormalities suggestive of Ia axon degeneration and/or regeneration. The multiple abnormal Ia fiber morphologies resulted in substantial variability in axonal width and inter-rotational distance (IRD). Likewise, db/db mice displayed significant variability in their IRDs compared with db(+) mice, suggesting that damage to Ia axons occurs in both type 1 and type 2 diabetes models. Insulin treatment improved behavioral deficits and restored Ia fiber innervation in comparison with nondiabetic mice.

Conclusions: Similar to small fibers, Ia axons are vulnerable to diabetes, and their damage may contribute to balance and gait deficits. In addition, these studies provide a novel method to assay therapeutic interventions designed for diabetes-induced large-fiber dysfunction.

Citing Articles

Characterization of sensory and motor dysfunction and morphological alterations in late stages of type 2 diabetic mice.

Tian T, Li H, Zhang S, Yang M Front Endocrinol (Lausanne). 2024; 15:1374689.

PMID: 38532899 PMC: 10964478. DOI: 10.3389/fendo.2024.1374689.


Plasma exosomes improve peripheral neuropathy via miR-20b-3p/Stat3 in type I diabetic rats.

Li J, Wu G, Li W, Zhou X, Li W, Xu X J Nanobiotechnology. 2023; 21(1):447.

PMID: 38001489 PMC: 10675980. DOI: 10.1186/s12951-023-02222-5.


Vincamine as an agonist of G-protein-coupled receptor 40 effectively ameliorates diabetic peripheral neuropathy in mice.

Xu J, Xu X, Ling Y, Wang Y, Huang Y, Yang J Acta Pharmacol Sin. 2023; 44(12):2388-2403.

PMID: 37580494 PMC: 10692181. DOI: 10.1038/s41401-023-01135-1.


Genetic exploration of roles of acid-sensing ion channel subtypes in neurosensory mechanotransduction including proprioception.

Lin Y, Lee C, Sung J, Chen C Exp Physiol. 2023; 109(1):66-80.

PMID: 37489658 PMC: 10988671. DOI: 10.1113/EP090762.


Emerging Nonpharmacologic Interventions to Treat Diabetic Peripheral Neuropathy.

Enders J, Elliott D, Wright D Antioxid Redox Signal. 2022; 38(13-15):989-1000.

PMID: 36503268 PMC: 10402707. DOI: 10.1089/ars.2022.0158.